Figure 5.

The treatment effects of 10 mg everolimus (E10) for patients from the everolimus arm (n = 272) who had at least 1 dose reduction to 5 mg and/or 0 mg (n = 174) versus no dose reduction (n = 98). The line within the grey box indicates the median value, the grey box indicates the upper and lower quartile, and the grey lines above and below the box indicate the 5th and 95th percentiles.

Stein et al. BMC Cancer 2012 12:311   doi:10.1186/1471-2407-12-311
Download authors' original image